In that sense, loss-of-function mutations in KEAP1 gene – leading to higher NRF2 activation – have been identified in several human adenocarcinoma, with lung cancer being the type where this gene is most mutated34. This evidence concerns the gene NFE2L2 and adenocarcinoma.